Brian S. Henick

Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels

Biagio Ricciuti, Xinan Wang, Joao V. Alessi et al. · JAMA Oncology · 2022 · 356 citations · Full text

EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer

Katherine Hastings, Helena A. Yu, Wen Wei et al. · Annals of Oncology · 2019 · 352 citations · Full text

Immune Cell PD-L1 Colocalizes with Macrophages and Is Associated with Outcome in PD-1 Pathway Blockade Therapy

Yuting Liu, Jon Zugazagoitia, Fahad Shabbir Ahmed et al. · Clinical Cancer Research · 2019 · 326 citations · Full text

Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non–Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis

Ila Datar, Miguel F. Sanmamed, Jun Wang et al. · Clinical Cancer Research · 2019 · 320 citations · Full text

Randomized, Open-Label Phase III Trial of Docetaxel Plus High-Dose Calcitriol Versus Docetaxel Plus Prednisone for Patients With Castration-Resistant Prostate Cancer

Howard I. Scher, Xiaoyu Jia, Kim Chi et al. · Journal of Clinical Oncology · 2011 · 247 citations · Full text